Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Boehringer Ingelheim
Federal Trade Commission
Fish and Richardson
Harvard Business School
Express Scripts
Farmers Insurance
Deloitte
Cerilliant
Chubb

Generated: August 19, 2017

DrugPatentWatch Database Preview

PLETAL Drug Profile

« Back to Dashboard

Which patents cover Pletal, and when can generic versions of Pletal launch?

Pletal is a drug marketed by Otsuka and is included in one NDA.

The generic ingredient in PLETAL is cilostazol. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cilostazol profile page.

Summary for Tradename: PLETAL

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list81
Clinical Trials: see list10
Patent Applications: see list3,959
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PLETAL at DailyMed

Pharmacology for Tradename: PLETAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka
PLETAL
cilostazol
TABLET;ORAL020863-001Jan 15, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
Otsuka
PLETAL
cilostazol
TABLET;ORAL020863-002Jan 15, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PLETAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Otsuka
PLETAL
cilostazol
TABLET;ORAL020863-001Jan 15, 1999► Subscribe► Subscribe
Otsuka
PLETAL
cilostazol
TABLET;ORAL020863-002Jan 15, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Medtronic
AstraZeneca
McKinsey
UBS
Fuji
Julphar
QuintilesIMS
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot